Inventor · disambiguated record
Martin Bryant
Also filed as: BRYANT MARTIN · BRYANT MARTIN L
25 granted patents·24 pending applications·1,183 citations·filing 1994–2013
97Inventor score
Top patents by PatentIndex Score
49 records- 0198US6566344B1β-L-2′-deoxy-nucleosides for the treatment of hepatitis BIDENIX PHARMACEUTICALS INC·Filed 2001·Granted May 20, 2003·122 cites·105 claims
- 0297US6875751B23′-prodrugs of 2′-deoxy-β-L-nucleosidesIDENIX PHARMACEUTICALS INC·Filed 2001·Granted Apr 5, 2005·131 cites·25 claims
- 0397US6787526B1Methods of treating hepatitis delta virus infection with β-L-2′-deoxy-nucleosidesIDENIX PHARMACEUTICALS INC·Filed 2002·Granted Sep 7, 2004·93 cites·25 claims
- 0497US6569837B1β-L-2′-deoxy pyrimidine nucleosides for the treatment of hepatitis BIDENIX PHARMACEUTICALS INC·Filed 2001·Granted May 27, 2003·98 cites·49 claims
- 0595US6596700B2Methods of treating hepatitis delta virus infection with β-L-2'-deoxy-nucleosidesIDENIX PHARMACEUTICALS INC·Filed 2001·Granted Jul 22, 2003·61 cites·57 claims
- 0695US6395716B1β-L-2′-deoxy-nucleosides for the treatment of hepatitis BNOVIRIO PHARMACEUTICALS LTD·Filed 1999·Granted May 28, 2002·124 cites·27 claims
- 0794US7585851B23′-prodrugs of 2′-deoxy-β-L-nucleosidesIDENIX PHARMACEUTICALS INC·Filed 2004·Granted Sep 8, 2009·69 cites·112 claims
- 0894US6946450B2β-L-2′-deoxy-nucleosides for the treatment of hepatitis BUNIV MONTPELLIER II·Filed 2003·Granted Sep 20, 2005·30 cites·81 claims
- 0994US6545021B1Use of substituted-1,5-dideoxy-1,5-imino-D-glucitol compounds for treating hepatitis virus infectionsSEARLE & CO·Filed 2000·Granted Apr 8, 2003·56 cites·27 claims
- 1093US7465574B2Recombinant RSV virus expression systems and vaccinesMEDIMMUNE LLC·Filed 2005·Granted Dec 16, 2008·14 cites·8 claims
- 1192US6444652B1β-L-2'-deoxy-nucleosides for the treatment of hepatitis BNOVIRIO PHARMACEUTICALS LTD·Filed 1999·Granted Sep 3, 2002·91 cites·34 claims
- 1289US7304043B2β-L-2′-deoxy-nucleosides for the treatment of hepatitis BIDENIX PHARMACEUTICALS INC·Filed 2005·Granted Dec 4, 2007·8 cites·24 claims
- 1388US6545007B2Methods for inhibiting the transmission of HIV using topically applied substituted 6-benzyl-4-oxopyrimidinesIDENIX CAYMAN LTD·Filed 2001·Granted Apr 8, 2003·24 cites·43 claims
- 1485US6194391B13′-azido-2′,3′-dideoxyuridine administration to treat HIV and related test protocolUNIV EMORY·Filed 1999·Granted Feb 27, 2001·65 cites·32 claims
- 1585US5622972AMethod for treating a mammal infected with respiratory syncytial virusSEARLE & CO·Filed 1996·Granted Apr 22, 1997·73 cites·12 claims
- 1684US7795238B2β-L-2′-deoxy-nucleosides for the treatment of hepatitis BIDENIX PHARMACEUTICALS INC·Filed 2007·Granted Sep 14, 2010·3 cites·18 claims
- 1783US6515028B1Glucamine compounds for treating hepatitis virus infectionsSEARLE & CO·Filed 2000·Granted Feb 4, 2003·13 cites·58 claims
- 1882US6602664B23′-azido-2′,3′-dideoxyuridine in an anti-HIV effectiveness test protocolUNIV EMORY·Filed 2001·Granted Aug 5, 2003·13 cites·10 claims
- 1980US2011195922A9Beta-L-2'-Deoxy-Nucleosides for the Treatment of Hepatitis BIDENIX PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 2078US7205013B2Recombinant RSV virus expression systems and vaccinesMEDIMMUNE VACCINES INC·Filed 2004·Granted Apr 17, 2007·4 cites·10 claims
- 2176US6809083B1Use of N-substituted-1, 5-dideoxy-1, 5-imino-D-glucitol compounds for treating hepatitis virus infectionsFiled 1999·Granted Oct 26, 2004·31 cites·3 claims
- 2271US2009175899A1Recombinant rsv virus expression systems and vaccinesMEDIMMUNE LLC·Filed 2008·Application pending·0 cites
- 2368US2006025375A1Beta-L-2'-deoxy-nucleosides for the treatment of hepatitis BIDENIX PHARMACEUTICALS INC·Filed 2005·Application pending·0 cites
- 2467US9290533B2β-L-2′-deoxy-nucleosides for the treatment of hepatitis BNOVARTIS AG·Filed 2013·Granted Mar 22, 2016·0 cites·8 claims
- 2567US2009274727A1Recombinant RSV Virus Expression Systems And VaccinesMEDIMMUNE LLC·Filed 2009·Application pending·0 cites
- 2665US2010028377A1Recombinant RSV Virus Expression Systems And VaccinesMEDIMMUNE LLC·Filed 2009·Application pending·0 cites
- 2763US6069235AMethod for carbohydrate engineering of glycoproteinsMONSANTO CO·Filed 1994·Granted May 30, 2000·24 cites·3 claims
- 2863US2007087995A1beta-L-2'-Deoxy-Nucleosides for the Treatment of Hepatitis BUNIV MONTPELLIER II·Filed 2006·Application pending·0 cites
- 2962US2012264707A1Beta-l-2'-deoxy-nucleosides for the treatment of hepatitis bGOSSELIN GILLES·Filed 2012·Application pending·0 cites
- 3062US2008279892A1Recombinant RSV Virus Expression Systems And VaccinesMEDIMMUNE VACCINES INC·Filed 2007·Application pending·0 cites
- 3161US2006106044A1Methods for inhibiting the transmission of HIV using topically applied substituted 6-benzyl-4-oxopyrimidinesIDENIX PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 3261US2004234506A1Recombinant RSV virus expression systems and vaccinesAVIRON INC·Filed 2004·Application pending·0 cites
- 3361US2003225114A1Methods for inhibiting the transmission of HIV using topically applied substituted 6-benzyl-4- oxopyrimidinesIDENIX PHARMACEUTICALS INC·Filed 2003·Application pending·0 cites
- 3460US6100277ARetroviral protease inhibitor combinationsSEARLE & CO·Filed 1995·Granted Aug 8, 2000·27 cites·8 claims
- 3560US2008064655A1Beta-L-2'-Deoxy-Nucleosides for the Treatment of Hepatitis BINDENIX PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
- 3660US2011257120A1Beta-l-2'-deoxy-nucleosides for the treatment of hepatitis bIDENIX PHARMACEUTICALS INC·Filed 2011·Application pending·0 cites
- 3759US2012308602A1Recombinant RSV Virus Expression Systems And VaccinesJIN HONG·Filed 2012·Application pending·0 cites
- 3858US6747149B2Glucamine salts for treating hepatitis virus infectionsSEARLE & CO·Filed 2002·Granted Jun 8, 2004·0 cites·13 claims
- 3957US2006240410A1Retroviral protease inhibitor combinationsSEARLE & CO·Filed 2006·Application pending·0 cites
- 4057US2006264468A1Use of substituted-1, 5-dideoxy-1, 5-imino-D-glucitol compounds for treating hepatitis virus infectionsUNITED THERAPEUTICS CORP·Filed 2006·Application pending·0 cites
- 4156US2003225028A1Beta-L-2'deoxy-nucleosides for the treatment of hepatitis BFiled 2003·Application pending·0 cites
- 4254US2005267153A1Use of N-substituted-1,5-dideoxy-1,5-imino-D-glucitol compounds for treating hepatitis virus infectionsMUELLER RICHARD A·Filed 2004·Application pending·0 cites
- 4353US2003027321A1Recombinant RSV virus expression systems and vaccinesAVIRON INC·Filed 2001·Application pending·0 cites
- 4453US2003220299A1Use of substituted-1,5-dideoxy-1,5-imino-D-glucitol compounds for treating hepatitis virus infectionsSEARLE & CO·Filed 2003·Application pending·0 cites
- 4552US2011045023A1Recombinant RSV Virus Expression Systems And VaccinesMEDIMMUNE LLC·Filed 2010·Application pending·0 cites
- 4651US2003207813A1Retroviral protease inhibitor combinationsSEARLE & CO·Filed 2002·Application pending·0 cites
- 4750US6830748B1Recombinant RSV virus expression systems and vaccinesMEDIMMUNE VACCINES INC·Filed 1999·Granted Dec 14, 2004·9 cites·8 claims
- 4849US2005158340A1Recombinant RSV virus expression systems and vaccinesMEDIMMUNE VACCINES INC·Filed 2005·Application pending·0 cites
- 4940US2005119310A1Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds for treating hepatitis virus infectionsFiled 2001·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →